News Industry News Two Differing Blood Clot Prevention Medications Used During Heart Procedure Are Both Safe and Effective for Patients, New Study Finds November 21, 2016
News Daily News New USPSTF Guidelines Recommend Statins in ‘Appropriately Selected’ Primary-Prevention Patients Michael O'Riordan November 13, 2016
News Daily News Newest Atherosclerosis Risk Calculator Aims to Adjust Predictions as Prevention Tactics Kick In Yael L. Maxwell November 10, 2016
News Daily News Pharmacist Management of High Cholesterol Gets More Patients to Goal, Lowers LDL Levels: RxACT Michael O'Riordan September 29, 2016
News Daily News Nearly 40% of Diabetic Patients Not Treated With Statins: PINNACLE Registry Michael O'Riordan September 13, 2016
News Daily News Review Touts Benefits of Statins, Seeks to Dispel Safety Concerns Todd Neale September 12, 2016
News Daily News Improved Adherence to Medical Therapy Reduces CVD Events in Secondary Prevention Patients Michael O'Riordan August 16, 2016
News Daily News Time for Niacin to Be ‘Relegated to Medical History’ as HPS2-THRIVE Analysis Confirms Drug’s Failings Michael O'Riordan July 12, 2016
News Daily News Chinese Patients With A-fib Are at Especially High Risk of Stopping Warfarin Todd Neale July 08, 2016
News Daily News Aspirin as Standalone Stroke Protection Still Overused for Patients With A-fib Todd Neale June 27, 2016
News Daily News Rivaroxaban May Help Dissolve Left Atrial Thrombus in Patients With A-fib Todd Neale June 09, 2016
News Daily News USPSTF Tightens Up Primary-Prevention Recommendations, Saying Aspirin Should Be Used Only in High-Risk Individuals Michael O'Riordan April 12, 2016
News Industry News New Haven Pharmaceuticals Presents Positive Data That Shows DURLAZA™ is Well Tolerated and Delivers Sustained 24-hour Antiplatelet Control March 01, 2016
News Daily News Trial Affirms Aspirin Is Safe to Continue Before Coronary Artery Surgery Todd Neale February 25, 2016
News Conference News AHA 2015 CANOA: Fewer Migraines With Clopidogrel Plus Aspirin Post-ASD Closure Shelley Wood November 08, 2015
News Industry News New Haven Pharmaceuticals Receives FDA Approval for DURLAZA™ (aspirin) Extended Release Capsules for Secondary Prevention of Stroke and Acute Cardiac Events September 08, 2015
Presentation ACC 2015 Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin Presenter: Marc S. Sabatine March 14, 2015